Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Staging
93 results:

  • 1. Association of Fusobacterium nucleatum infection with the clinicopathological characteristics in colorectal cancer patients.
    Pang SW; Armon S; Chook JB; Chew J; Peh KB; Lim WW; Peh SC; Teow SY
    Mol Biol Rep; 2024 Jan; 51(1):124. PubMed ID: 38227097
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Node-negative colon cancer: histological, molecular, and stromal features predicting disease recurrence.
    Strous MTA; van der Linden RLA; Gubbels ALHM; Faes TKE; Bosscha K; Bronkhorst CM; Janssen-Heijnen MLG; de Bruïne AP; Vogelaar FJ
    Mol Med; 2023 Jun; 29(1):77. PubMed ID: 37344790
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epidemiological and molecular evaluation of BRAF, kras, NRAS genes and MSI in the development of colorectal cancer.
    Paula Simedan Vila A; Helena Rodrigues G; Leite Marzochi L; Garcia de Oliveira-Cucolo J; Lívia Silva Galbiatti-Dias A; Felipe Maciel Andrade R; de Santi Neto D; Gomes Netinho J; Castiglioni L; Cristina Pavarino É; Maria Goloni-Bertollo E
    Gene; 2023 Jun; 870():147395. PubMed ID: 36990254
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with colorectal Carcinoma.
    Aktar S; Hamid FB; Gamage SMK; Cheng T; Parkneshan N; Lu CT; Islam F; Gopalan V; Lam AK
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902476
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Thirty-Year-Old Male Patient with Non-Seminoma and Coincidental Rectal cancer.
    Nolting J; Dräger DL; Hakenberg OW; Schneidewind L
    Urol Int; 2023; 107(4):429-432. PubMed ID: 36652931
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The relationships of OSBPL3 expression with KI-67 expression and kras mutations in CRC: implications for diagnosis and prognosis.
    Zhang M; Meng L; Zhang Z; Wu J; Chen X; Wang Y; He J
    BMC Med Genomics; 2022 Dec; 15(1):259. PubMed ID: 36517805
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients.
    Crutcher MM; Snook AE; Waldman SA
    Expert Rev Clin Pharmacol; 2022 Nov; 15(11):1317-1326. PubMed ID: 36259230
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Alarming Drop in Early Stage colorectal cancer Diagnoses After COVID-19 Outbreak: A Real-World Analysis from the Italian COVID-DELAY Study.
    Mentrasti G; Cantini L; Zichi C; D'Ostilio N; Gelsomino F; Martinelli E; Chiari R; La Verde N; Bisonni R; Cognigni V; Pinterpe G; Pecci F; Migliore A; Aimar G; De Vita F; Traisci D; Spallanzani A; Martini G; Nicolardi L; Cona MS; Baleani MG; Rocchi MLB; Berardi R
    Oncologist; 2022 Sep; 27(9):e723-e730. PubMed ID: 35815922
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognosis prediction of stage IV colorectal cancer patients by mRNA transcriptional profile.
    Wu B; Yang J; Qin Z; Yang H; Shao J; Shang Y
    Cancer Med; 2022 Dec; 11(24):4900-4912. PubMed ID: 35587572
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. HIPK2 Cooperates with kras Signaling and Associates with colorectal cancer Progression.
    Di Segni M; Virdia I; Verdina A; Amoreo CA; Baldari S; Toietta G; Diodoro MG; Mottolese M; Sperduti I; Moretti F; Buglioni S; Soddu S; Di Rocco G
    Mol Cancer Res; 2022 May; 20(5):686-698. PubMed ID: 35082165
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pathological Features and Prognostication in colorectal cancer.
    Chen K; Collins G; Wang H; Toh JWT
    Curr Oncol; 2021 Dec; 28(6):5356-5383. PubMed ID: 34940086
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic value of lymphovascular invasion in stage II colorectal cancer patients with an inadequate examination of lymph nodes.
    Gao Z; Cao H; Xu X; Wang Q; Wu Y; Lu Q
    World J Surg Oncol; 2021 Apr; 19(1):125. PubMed ID: 33866973
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
    BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Next-Generation Sequencing of 487 Esophageal Adenocarcinomas Reveals Independently Prognostic Genomic Driver Alterations and Pathways.
    Sihag S; Nussenzweig SC; Walch HS; Hsu M; Tan KS; Sanchez-Vega F; Chatila WK; De La Torre SA; Patel A; Janjigian YY; Maron S; Ku GY; Tang LH; Hechtman J; Shah PM; Wu AJ; Jones DR; Molena D; Solit DB; Schultz N; Berger MF
    Clin Cancer Res; 2021 Jun; 27(12):3491-3498. PubMed ID: 33795256
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology].
    Navarro S; Cuatrecasas M; Hernández-Losa J; Landolfi S; Musulén E; Ramón Y Cajal S; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; García-Alfonso P
    Rev Esp Patol; 2021; 54(1):41-54. PubMed ID: 33455693
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The Unmet Needs of the Diagnosis, staging, and Treatment of Gastrointestinal Tumors.
    Halama N; Haberkorn U
    Semin Nucl Med; 2020 Sep; 50(5):389-398. PubMed ID: 32768003
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Update of the recommendations for the determination of biomarkers in colorectal carcinoma: National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.
    García-Alfonso P; García-Carbonero R; García-Foncillas J; Pérez-Segura P; Salazar R; Vera R; Ramón Y Cajal S; Hernández-Losa J; Landolfi S; Musulén E; Cuatrecasas M; Navarro S
    Clin Transl Oncol; 2020 Nov; 22(11):1976-1991. PubMed ID: 32418154
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The Impact of kras Mutation on the Presentation and Prognosis of Non-Metastatic Colon cancer: an Analysis from the National cancer Database.
    Scott A; Goffredo P; Ginader T; Hrabe J; Gribovskaja-Rupp I; Kapadia MR; Weigel RJ; Hassan I
    J Gastrointest Surg; 2020 Jun; 24(6):1402-1410. PubMed ID: 32128676
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Relative contribution of clinicopathological variables, genomic markers, transcriptomic subtyping and microenvironment features for outcome prediction in stage II/III colorectal cancer.
    Dienstmann R; Villacampa G; Sveen A; Mason MJ; Niedzwiecki D; Nesbakken A; Moreno V; Warren RS; Lothe RA; Guinney J
    Ann Oncol; 2019 Oct; 30(10):1622-1629. PubMed ID: 31504112
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and kras.
    Alwers E; Bläker H; Walter V; Jansen L; Kloor M; Arnold A; Sieber-Frank J; Herpel E; Tagscherer KE; Roth W; Chang-Claude J; Brenner H; Hoffmeister M
    BMC Cancer; 2019 Jul; 19(1):681. PubMed ID: 31296182
    [TBL] [Abstract] [Full Text] [Related]  


    of 5.